Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center study

Kamal S. Pohar,Sanjay Patel,Yair Lotan,Edouard Trabulsi,Michael Woods,Tracy Downs,William C. Huang,Jeffrey Jones,Jennifer Taylor,Michael O'Donnell,Trinity J. Bivalacqua,Joel DeCastro,Gary Steinberg,Ashish M. Kamat, Matthew J. Resnick,Badrinath Konety,Mark Schoenberg,J. Stephen Jones,Siamak Daneshmand

Urologic Oncology: Seminars and Original Investigations（2022）

引用 3|浏览30

暂无评分

摘要

•Repeat instillation of hexaminolevulinate (HAL) is safe.•Systemic adverse reactions from HAL are rare.•HAL is safe following recent intravesical Bacillus Calmette-Guérin.

查看译文

关键词

Bladder cancer,Hexaminolevulinate,HAL,Blue light cystoscopy,Safety

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要